Aura Biosciences
Price chart
Anonymous reader poll. Unscientific, not investment advice.
✦ StockVane Quant Insights how this is computed
- Mid-pack momentum — held if you own it, not a fresh buy.
- Signal has read HOLD for 1 week.
- Recent price momentum is +8.4% on average (3-month/1-year).
- Main-fund capital flow has been a net inflow over the last 45 sessions.
- Short interest has risen to 10.1% of float.
- Analyst tilt is Buy.
- Price is above its 20-day average and above its 60-day average.
- The 20-day average is above the 60-day average, a short-term uptrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Performance
Key statistics
Price & volume
- Prev close
- 6.98
- Open
- 6.51
- Day range
- 6.51 - 6.98
- Avg price
- 6.87
- Volume
- 791.13K
- Turnover
- 5.43M
- Turnover ratei
- 1.06%
- Volume ratioi
- 1.24
- Amplitudei
- 6.73%
- 52-week rangei
- 4.73 - 9.54
Valuation
- P/Ei
- -3.90
- P/E (TTM)i
- -4.32
- P/Bi
- 2.49
- EPSi
- -1.76
- Book value / shi
- 2.76
- Net profit
- -183.17M
- Net assets
- 287.45M
Share structure
- Market cap
- 714.99M
- Float capi
- 512.86M
- Shares out
- 104.07M
- Float sharesi
- 74.65M
Dividend & listing
- Div yield (TTM)i
- 0.00%
- Dividend (TTM)
- 0.00
- Listing date
- 2021-10-29
27.9% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
+821.32K net over the window
Short interest
- Shares short
- 10.46M
- % of floati
- 10.09%
- Days to coveri
- 13.67
- As of
- 2026-10-30
Frequently asked questions
What is the current stock price of Aura Biosciences (AURA)?
Aura Biosciences last traded at 6.87. This page shows a periodic quote snapshot. Check the displayed quote time.
What is Aura Biosciences's market cap?
About 714.99M.
What is the P/E ratio of Aura Biosciences?
The trailing twelve-month P/E is -4.32. The Valuation tab shows it against the stock's own five-year range.
Does Aura Biosciences pay a dividend?
Aura Biosciences does not currently pay a regular dividend.
Is Aura Biosciences a buy according to analysts?
The consensus of 1 analysts is a Buy rating, with an average 12-month price target of 18.00, which implies 162.0% upside from the current price. This is not investment advice.
What is Aura Biosciences's StockVane Quant Rating?
The StockVane Momentum strategy currently rates Aura Biosciences a C (Hold). Mid-pack momentum — held if you own it, not a fresh buy. Not investment advice.
Quote time 2026-11-20 19:30:05 · For reference only, not investment advice and not tailored to your situation.
Aura Biosciences discussion 0 comments